Severe depression as a neuropsychiatric side effect induced by dolutegravir

Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital

(2017) SEJ Todd et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Psychiatric Symptoms in Patients Receiving Dolutegravir

(2017) Anna Fettiplace et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice

(2016) Mark G.J. de Boer et al.   AIDS

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients

(2016) C Hoffmann et al.   HIV MEDICINE

Psychiatric disorders after starting dolutegravir

(2015) Farid Kheloufi et al.   AIDS

48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-Analysis

(2014) Dipen A. Patel et al.   PLoS One